Paroxetine, Venlafaxine

Available monthly (starting at $35/mo) and quarterly (starting at $90/3 mo)
Both are recommended by the North American Menopause Society as a non-hormonal treatment for hot flashes.

Recommended by the North American Menopause Society

Estrogen and progesterone free

Free shipping

Free, unlimited follow-ups

Hot flashes

The science behind paroxetine

Paroxetine, in low doses, has been shown to be an effective and safe non-hormonal treatment for reducing the frequency and severity of hot flashes in menopausal women. Many women are not eligible for systemic hormone therapy, and others are concerned about the risks. Paroxetine is a powerful alternative to systemic estrogen-based medications (hormone replacement therapy).

The science behind venlafaxine

Venlafaxine has been shown to be an effective and safe non-hormonal treatment for significantly reducing the frequency and severity of hot flashes for menopausal women. Venlafaxine is in the family of medication called serotonin-norepinephrine reuptake inhibitors (SNRIs) and is most commonly used to treat anxiety and depression. However, it is also effective in decreasing the frequency and severity of hot flashes. Prior to non-hormonal treatments for hot flashes, the majority of care options were oral estrogen and progesterone, and now women have the option of effective non-hormonal treatment.

Important safety information

What you should know before taking paroxetine, venlafaxine

FAQ

To speak to a care representative, give us a call at (888) 798-8686 or email us at [email protected]

Paroxetine is part of a family of drugs called selective serotonin reuptake inhibitors (SSRIs) most commonly used to treat anxiety and depression. Ro-affiliated providers can prescribe paroxetine at lower doses than are typically required to treat anxiety and depression. At these lower doses, paroxetine may be effective in decreasing the frequency and severity of hot flashes.

The use of paroxetine for the treatment of hot flashes is an off-label use. Providers on the Ro platform have the discretion to prescribe paroxetine off-label if they believe it is an appropriate course of treatment based on a patient’s unique medical history, symptoms, and preferences.

Paroxetine is not appropriate for everyone—you and your provider will decide if paroxetine is appropriate for you. To learn more about who should not take paroxetine and the side effects that it may cause, including the boxed warning for increased suicidal thoughts in people under 25, please see the FAQ below regarding side effects and the important safety information for paroxetine.

Paroxetine is a tablet that is typically taken daily with or without food. Please, always follow your healthcare provider’s instructions for how to take your medication and what dose to take. If you have any questions about your medication, once prescribed, please contact your provider in your Ro account.

The North American Menopause Society (NAMS) reviewed clinical research pertaining to the treatment of hot flashes. NAMS found that women who benefited from SSRI treatment experienced a rapid reduction in the frequency and severity of hot flashes. Based on its review, NAMS recommends a trial of 2-4 weeks. If you are not getting any relief after 4 weeks, reach out to your Ro-affiliated physician, as this treatment does not work for everyone.

The FDA requires that drugs go through a clinical testing process to establish that they’re safe and effective to treat a particular condition. Healthcare providers generally may prescribe a drug for an unapproved use when they judge that it is medically appropriate for their patient. This type of prescribing is called “off-label” prescribing. Off-label prescribing practices are sometimes validated by clinical experience and research and may be a widely recognized clinical practice. Providers on the Ro platform have the discretion to prescribe certain drugs off-label based on a patient’s unique medical history, symptoms, and preferences.

Venlafaxine is part of a family of drugs called serotonin-norepinephrine reuptake inhibitors (SNRIs) most commonly used to treat anxiety and depression. Ro-affiliated providers can prescribe venlafaxine at lower doses than are typically required to treat depression and anxiety. At these lower doses, venlafaxine may be effective in decreasing the frequency and severity of hot flashes.

The use of venlafaxine for the treatment of hot flashes is an “off-label” use. Ro-affiliated providers have the discretion to prescribe venlafaxine off-label if they believe it is an appropriate course of treatment based on a patient’s unique medical history, symptoms, and preferences.

Venlafaxine is not appropriate for everyone—you and your provider will decide if venlafaxine is appropriate for you. To learn more about who should not take venlafaxine and the side effects that it may cause, including the boxed warning for increased suicidal thoughts in people under 25, please see the FAQ below regarding side effects and thee important safety information for venlafaxine.